| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 7.3 | 4.2 |
| Gross profit | 3.0 | 1.8 |
| Profit before tax | -0.3 | -4.6 |
| Net income | -0.3 | -4.6 |
| EPS (diluted, $ a share) | $-0.02 | $-0.47 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +75.1% |
|---|---|
| Gross margin | 41.3% |
| Operating margin | -33.4% |
10-Q filed with the SEC, NASDAQ: QTI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Qt Imaging Holdings, Inc.: key numbers
- Share price
- $1.80Close, Nov 16
- Market cap
- $26.4M
- Shares outstanding
- 14.69MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Electromedical & Electrotherapeutic ApparatusSIC 3845
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Qt Imaging Holdings, Inc.
All →Qt Imaging Holdings Investor Presentation
QT Imaging Holdings, Inc. has published an updated investor presentation to its website and filed it with the SEC. The presentation provides supplemental product and operational information regarding the company's Breast Acoustic CT Scanner technology. The filing is intended to provide current and potential investors with strategic highlights and technical details of the company's imaging platform.
QT Imaging Holdings Earnings Call: Key Takeaways
QTI reported strong 75% revenue growth but lowered 2026 guidance due to Middle East shipping delays, partially offset by a major CMS reimbursement milestone.
- Call
- Nov 10, 2026, 4:30 PM ET
Qt Imaging Holdings Financial Results
QT Imaging reported Q3 2026 revenue of $7.3 million, a 75% year-over-year increase, driven by the sale of 15 Breast Acoustic CT scanners. The company achieved a major regulatory milestone with CMS establishing a Medicare hospital outpatient payment pathway for diagnostic QTscan examinations effective January 1, 2027. Full-year 2026 revenue guidance was adjusted to approximately $34 million due to international shipment delays caused by conflict in the Middle East.
- Term
- Q3 2026
“Our third-quarter results demonstrate the continued growth of QT Imaging, with revenue increasing 75% year over year and reaching $21.3 million for the first nine months of 2026, approximately double the prior-year period.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging
“A major milestone is the recent CMS decision establishing separate Medicare hospital outpatient payment for medically necessary diagnostic QTscan examinations, effective January 1, 2027. Together with our dedicated billing code, effective October 1, this decision removes a significant reimbursement uncertainty and strengthens our ability to expand into U.S. hospitals and health systems.”
Dr. Raluca Dinu, Chief Executive Officer of QT Imaging